2022, Número S5
<< Anterior Siguiente >>
Cardiovasc Metab Sci 2022; 33 (S5)
Síndrome coronario crónico
Velásquez-Zapata L, Díaz-Pérez Y, Varleta P, Acevedo M
Idioma: Inglés [English version]
Referencias bibliográficas: 10
Paginas: s458-460
Archivo PDF: 139.58 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41: 407-477.
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 144: e368-e454.
Juarez-Orozco LE, Saraste A, Capodanno D, Prescott E, Ballo H, Bax JJ et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019; 20: 1198-1207.
Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001: CD001800.
Benzer W, Rauch B, Schmid JP, Zwisler AD, Dendale P, Davos CH et al. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry. Int J Cardiol. 2017; 228: 58-67.
Parker WA, Storey RF. Antithrombotic therapy for patients with chronic coronary syndromes. Heart. 2021; 107: 925-933.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41: 111-188.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020; 382: 1395-1407.
Perera D, Clayton T, O'Kane PD, Greenwood JP, Weerackody R, Ryan M et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022; 387: 1351-1360.
Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290: 86-97.